Archives: Agenda

• Setting up a local trial in Sweden: considerations and actions
• Communicating with multiple stakeholders
• Considering logistical requirements for personalized cell therapy: manufacturing, sites and patients
• Providing a small company perspective on cell therapy trial execution

• Integrating RWE into clinical trial design
• Using RWE to enhance or compliment traditional evidence generation
• Sharing successes and lessons learned

• Understand how pharmacovigilance roles and responsibilities align across sponsors, CROs, vendors, and investigators, and why clear roles prevent inefficiencies and issues
• Learn how biotech and specialty pharma can develop scalable pharmacovigilance strategies that adapt to dynamic pipelines
• Discover how hybrid outsourcing balances in-house oversight with external expertise for global coverage
• Explore methods to enhance partnerships so pharmacovigilance can support both compliance and operational delivery
• Recognize how a well-designed pharmacovigilance model can accelerate progress from early development to marketing approval

From IVRS to RTSM: a decade of evolution, innovation, and lessons learned

• Insights from 1,000 studies: what we have consistently seen, what has worked (and hasn’t)
• Emerging trends and innovations shaping the next generation of RTSM
• What sponsors are asking for: future expectations from RTSM providers

• Optimising supply chain demand forecasting to minimise waste
• Considering AI, tools and technologies to assist in end to end supply chain planning, management and visibility
• Creating a more joined up approach through communication with clinical teams

Accelerate, cultivate, innovate!

• Managing relationships with the modern supplier
• How Bayer’s external relationship governance model adds value to the business ensuring a reliable partnership and complements the sourcing & procurement functions within CTS scope
• Trends on procurement roles and the necessity to have an operational perspective
• Different approaches from different business necessities
• Trends on how to best manage CMOs, 3PLs and clinical trials partners

Consistent patient engagement is vital to clinical trial success, yet dropout and non-compliance remain persistent challenges. This session introduces gamification as a scientifically grounded strategy to boost retention, enhance adherence, and streamline trial execution.

• Understand the Science: Explore the behavioral and psychological foundations that make gamification a powerful tool for sustaining patient motivation
• See Real Results: Review real-world case studies where gamification significantly improved retention, compliance, and trial timelines
• Apply Proven Methods: Learn practical strategies and best practices for integrating gamified elements into clinical trial protocols